AI-Driven Prognostic Models in Traumatic Brain Injury Abstract Traumatic brain injury remains one of the most significant contributors to mortality and long term disability worldwide, affecting individuals across all age groups and placing a substantial burden on healthcare systems. It is a major cause of death
Benzodiazepine Deprescribing: Evidence-Based Approaches to Tapering, Alternative Therapies, and Managing Rebound Anxiety
Benzodiazepine Deprescribing Evidence-Based Approaches to Tapering, Alternative Therapies, and Managing Rebound Anxiety Abstract Benzodiazepine deprescribing has become an increasingly important clinical priority in contemporary practice, particularly as long term benzodiazepine use remains common among patients treated for anxiety disorders, insomnia, seizure disorders, muscle spasticity, and other chronic
Fibromyalgia and Lupus Together: Why Composite Disease Scores May Mislead Clinicians
Fibromyalgia and Lupus Together Why Composite Disease Scores May Mislead Clinicians Key Takeaways Accurate differentiation between fibromyalgia and systemic lupus erythematosus remains one of the most important challenges in rheumatologic practice, particularly because both conditions frequently coexist and share several subjective symptoms that can complicate clinical interpretation. In patients with
New Treatments for Atopic Dermatitis in 2026: Why More Options Might Be Making Your Choice Harder
New Treatments for Atopic Dermatitis in 2026 Why More Options Might Be Making Your Choice Harder Key Takeaways The treatment landscape for atopic dermatitis has changed profoundly over the past several years, moving from a limited set of broadly acting immunosuppressive therapies to an increasingly sophisticated range
Sarcopenia Clinics: Is It Time for a New Geriatric Subspecialty?
Sarcopenia Clinics Is It Time for a New Geriatric Subspecialty Abstract Sarcopenia has emerged as one of the most important age related musculoskeletal disorders in contemporary geriatric medicine. Characterized by progressive loss of skeletal muscle mass, reduced muscle strength, and impaired physical performance, sarcopenia contributes significantly to frailty, falls,
Invisible Signals: How Subtle Patient Behaviors Predict Clinical Outcomes
Invisible Signals: How Subtle Patient Behaviors Predict Clinical Outcomes Abstract Healthcare providers often focus on obvious clinical indicators when assessing patients, but research shows that subtle behavioral cues may offer equally valuable prognostic information. This paper examines the relationship between minor patient behaviors
Medicine Meets Mindfulness Can 10 Minutes a Day Really Change a Physician’s Life
Medicine Meets Mindfulness Can 10 Minutes a Day Really Change a Physician's Life Abstract Healthcare providers face increasing rates of burnout, stress, and mental health challenges that affect both personal well-being and patient care quality. This paper examines the evidence for brief daily
Chronic Kidney Disease in the Non-Diabetic Patient: What’s New and What Works?
Chronic Kidney Disease in the Non-Diabetic Patient: What’s New and What Works? Abstract Chronic kidney disease (CKD) represents a major global health challenge, affecting more than 850 million people worldwide and contributing substantially to cardiovascular morbidity, premature mortality, and escalating healthcare costs. Although diabetic kidney disease remains
Menopause Management in Primary Care: Current Evidence and Practical Prescribing of Menopausal Hormone Therapy
Menopause Management in Primary Care Current Evidence and Practical Prescribing of Menopausal Hormone Therapy Abstract Menopause is a normal biological transition that marks the permanent cessation of ovarian follicular activity and the end of reproductive capacity. Clinically, it is diagnosed retrospectively after twelve consecutive months
Post-COVID Pulmonary Changes: Are “Routine” Cases Now Higher Risk?
Post-COVID Pulmonary Changes Are “Routine” Cases Now Higher Risk Abstract The COVID 19 pandemic has produced lasting consequences that extend far beyond the acute infectious phase, fundamentally reshaping respiratory medicine, perioperative evaluation, and risk assessment across multiple clinical disciplines. Although the acute burden of severe SARS
